Bioavailability of Cefaclor Capsules Using an Improved Analytical Method of Cefaclor in Human Plasma
![]() |
Kim, Tae-Wan
(College of Pharmacy, Kangwon National University)
Song, Ok-Kyoung (College of Pharmacy, Kangwon National University) Han, Sun-Young (College of Pharmacy, Kangwon National University) Cao, Qing-Ri (College of Pharmacy, Kangwon National University) Park, Mi-Jin (College of Pharmacy, Kangwon National University) Kang, Sung-Ha (Hallym Medical Center) Shin, Kwan-Seog (College of Pharmacy, Kangwon National University) Cui, Jing-Hao (College of Pharmacy, Yanbian University) Lee, Beom-Jin (College of Pharmacy, Kangwon National University) |
1 | M. Tutunji, O. Jarrar, M. Musameh, S.M. Alam and R. Dham, Bioequivalence evaluation of two brands of cefaclor 500mg capsules: quantification of cefaclor using solid phase extraction technique. J. Clin. Pharm. Ther., 26, 149-153 (2001) DOI ScienceOn |
2 | H. Sourgens, H. Derendorf and H. Schifferer, Pharmacokinetic profile of cefaclor, Int. J. Clin. Pharmacol. Ther., 35, 374-380 (1997) |
3 | Cefaclor capsules and suspension-'in-vivo bioequivalence and in-vivo dissolution testing', General information/In vivo bioequivalence guideline, USP 24, 2067-2068 |
4 | P.M. Kovach and R.J. Lantz, High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine, J. Chromatogr., 567, 129-39 (1991) DOI ScienceOn |
![]() |